← All trials
NCT00747747
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2007
- Primary completion
- Jan 1, 2009
- Completion date
- Feb 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 49
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Galsor S.r.l.Lead sponsor
- Universita' Cattolica del Sacro CuoreOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.